Life Sciences and Healthcare

Strategic Transaction
Advisory

Your specialist firm for strategic company development. Internationalization. Value Creation. Growth.

Looking for Life Sciences and Healthcare experts?

Get in touch

Vinc supports Life Sciences and Healthcare companies with strategic consulting as well as the strategic execution and implementation throughout their entire business cycles. From company growth to succession and company sale.

Get in touch

Creative strategic advice, persistent execution

Approach

Vinc was founded to help small and medium-sized companies in the life sciences and healthcare sectors achieve international growth and create long-term value. We provide comprehensive support at every stage, from early development to global expansion, with a 100% focus on life sciences and healthcare. What sets us apart is our combination of strategic guidance and hands-on execution. We don't just advise, we actively implement the solutions needed for sustainable growth. Acting as both, trusted partners and execution specialists, we collaborate closely with our clients to drive success in an increasingly competitive global market.

Combining independent strategy consulting and financial advisory – Strategic Transaction Advisory.

Through our partnership with Munich based ISP Healthcare, VINC  strengthens its commitment to supporting clients with enhanced, end-to-end Value Creation and Growth Strategies as well as a structured execution support in the thriving Life Sciences market.

We’re really blessed to have found VincAdvisory, as a specialist Life Sciences M&A advisory firm for our European acquisition initiatives. Due to their industry specialization, they immediately understood our business, quickly familiarized themselves with our company and acquisition strategy and helped us in identifying and speaking to the right fit targets. Their entrenchment within the industry and their relationships with small- and medium sized company owners and owner families is unparalleled. Being headquartered in the US, this has been truly helpful to SPX Flow.

Vusa Mlingo
VP Corporate Development & Strategy – SPX FLOW, US

We have been in contact with Thomas and Vinc for more than 5 years, ever since he pro-actively reached out to us. Since then, he has been our gateway to the pharma CRO industry in Europe and our one-stop shop to understand the pharma CRO industry, to identify potential opportunities, to increase our scale and to run the M&A process. Thomas and his team combine a deep knowledge & network with a creative & entrepreneurial mindset to come up with innovative constellations.

Koen de Witte
CEO and Shareholder - reMYND, BE

It was a pleasure working with the teamof Vinc - on the other side(!). Vinc is a very professional organization within-depth industry expertise – top league for mid-market transactions – and haveclearly helped the sellers in the best way.

Gijs Botman
Managing Partner - Mentha Capital, NL

Full range of strategic advisory services for transformational transactions

Services

With Vinc’s holistic advisory approach, we excel in tailor-made and solution oriented project execution, helping our clients to overcome their most challenging issues.

M&A Advisory

Vinc is a leading advisor in buy-side transactions and buy&build strategies, providing expert guidance throughout the entire M&A process. Complementing the service portfolio, Vinc supports in sale and carve-out preparation, exit readiness, commercial due diligence, company and plant sales, joint ventures, strategic alliances, and post-merger strategy.

Product Advisory

Vinc executes international pre-commercial and commercial-stage licensing transactions, product and product portfolio sales and acquisitions, R&D/patent sales and acquisitions, as well as royalty monetization transactions.

Check out our
Licensing Partnership Services

Financial Advisory

We help our clientswith tailor-made financial structuring, valuation and fairness opinions,defense strategies, debt financings, equity capital market transactions,project financings, recapitalizations, fundraisings.

Committee Advisory

We provide independent, special advisory services to company management, shareholders and executive committees with respect to value creation topics, M&A strategies, growth and market entry strategies as well as shareholder relations.

Looking for Life Sciences and Healthcare experts?

Get in touch

We look forward to discussing your specific needs and to developing a compelling project for you internationalisation, value creation and growth.

Get in touch

Our offering to you

Company Acquisitions
+

Company Acquisitions

  • Targeted Acquisition Strategy: We identify and assess potential acquisition targets aligned with your strategic goals, leveraging industry expertise and market insights to ensure a high-value fit.
  • Structured Outreach & Activation: We employ a tailored outreach and engagement process to connect with target companies, maximizing actionability and increasing the likelihood of a successful deal.
  • Seamless Negotiation & Closing Support: From initial negotiations to closing, we guide you through every stage, handling complex deal structuring, regulatory considerations, and documentation to achieve optimal transaction outcomes.
  • Buy-and-build execution
    +

    Buy-and-build execution

  • Strategic Growth Blueprint: We develop a customized growth plan, identifying acquisition opportunities that complement your core business and align with long-term value creation goals.
  • Disciplined Acquisition Pipeline: Leveraging a systematic approach, we build and maintain a targeted acquisition pipeline, ensuring strategic fit and scalability for your buy-and-build objectives.
  • Integration & Synergy Realization: Our team supports seamless integration and synergy capture, focusing on operational efficiencies, cultural alignment, and value creation to optimize the expanded platform’s performance.
  • CEO Sparring
    +

    CEO Sparring

    • Outside-in perspective and independent party
    • Trust, Industry Knowledge and Market Insights
    • "Safe space" to challenge and develop the most relevant strategic topics
    Company Succession
    +

    Company Succession

  • Tailored Succession Planning: We work closely with business owners to design a personalized succession strategy, ensuring a smooth transition that preserves the company’s legacy and aligns with personal and business goals.
  • Comprehensive Successor Identification: Our team conducts a targeted search to identify and vet suitable successors, whether internal candidates, family members, or external buyers, maximizing continuity and cultural alignment.
  • Seamless Transition Support: We manage the entire succession process, from negotiations and valuation to final transition, ensuring stability and long-term success for the business and its stakeholders.
  • Commerical Due Diligence
    +

    Commerical Due Diligence

  • In-Depth Market Analysis: Together with ISP Healthcare, we conduct rigorous market assessments to evaluate competitive dynamics, market growth, and positioning, ensuring you have a clear understanding of the target’s market landscape.
  • Customer & Revenue Validation: Our joint expertise enables us to perform detailed customer and revenue analyses, assessing sustainability and growth potential of the target’s business model.
  • Strategic Fit & Risk Assessment: We provide actionable insights on the target’s strategic fit, highlighting key risks and opportunities to strengthen your acquisition decisions.
  • Carve-Outs
    +

    Carve-Outs

  • Strategic Separation Planning: We design tailored carve-out strategies to effectively separate the divested entity, aligning with both seller and buyer objectives while maintaining operational continuity.
  • Detailed Financial & Operational Analysis: Our team conducts comprehensive assessments to identify standalone requirements and optimize the financial and operational setup, ensuring the divested entity’s independent success.
  • Seamless Transition & Integration Support: From deal negotiation to post-close support, we manage the transition process, facilitating smooth handovers and integration planning to maximize value capture for both parties.
  • Company Sale
    +

    Company Sale

    • Strategic Sale Preparation: We work with you to optimize company value by identifying growth drivers, addressing potential concerns, and positioning the business attractively for prospective buyers.
    • Targeted Buyer Outreach: Leveraging our extensive network, we conduct a targeted outreach to qualified buyers, increasing interest and competition to maximize sale price and terms.
    • End-to-End Transaction Management: From initial valuation to closing, we manage every step of the sale process, including negotiations, due diligence, and documentation, ensuring a smooth, successful transaction.
    In-/Out-Licensing
    +

    In-/Out-Licensing

  • Strategic Partner Identification: Through our licensing arm, we leverage our network and industry insights to identify and evaluate potential licensing partners aligned with your strategic goals, whether for in- or out-licensing opportunities.
  • Value-Driven Deal Structuring: Our team develops tailored deal structures, focusing on key terms such as royalties, milestones, and exclusivity to maximize value for both parties while mitigating risk.
  • Negotiation & Execution Support: From initial discussions to contract execution, our licensing team manages the entire licensing process, ensuring alignment on strategic goals and facilitating smooth collaboration between all parties involved.
  • Full range of strategic advisory services for transformational transactions

    Case studies

    Our Team has an extensive industry network and deep sector knowledge. The strong personal relationships with key decision makers in the Life Sciences and Healthcare industry, combined with our passion, dedication and determination allows us to provide a particular value-add for your project and/or transaction.

    Asset Evaluation and Carve-Out
    +

    Asset Evaluation and Carve-Out

    • Identification and evaluation of best-fit partner
    • Cross-Cultural “Moderator”
    • Deal Structuring and Negotiations
    • Momentum kept in Covid crisis peak
    Targeted Acquisition (BE, ES, UK)
    +

    Targeted Acquisition (BE, ES, UK)

    • Private Equity backed buy&build add-on
    • Technology focussed, best-fit target company identification
    • Cross-border project management and high-speed transaction execution
    • 4 weeks from first contact to signing
    C-Suite Sparring (DE)
    +

    C-Suite Sparring (DE)

    • Evaluation of strategic options 
    • Development of (flexible) company presentation for external communication
    • Business Plan and roadmap going forward

    Company Sale (CH, DE, NL)
    +

    Company Sale (CH, DE, NL)

    • Exclusive sell-side mandate and process execution 
    • Complex exit and transaction structure with numerous sellers
    • Transition from Venture Capital to Private Equity

    M&A Strategy and Deal execution
    +

    M&A Strategy and Deal execution

    • Industry mapping and strategic avenue definition
    • Structured target sourcing, qualification and activation
    • Deal-structuring and negotiation support
    • In parallel to signing of first deal, multiple add-ons in the pipeline
    Platform-strategy definition and target pipeline build-up
    +

    Platform-strategy definition and target pipeline build-up

    • Identification of strategic avenues and platform targets
    • Preparation for add-on acquisitions
    • Pipeline build-up and evaluation

    In-depth expertise across the convergent Healthcare & Life Sciences industry – from research to real-world impact

    Expertise

    Vinc’s unparalleled specialization andlong-standing expertise lies within the pharmaceutical development chain aswell as in the MedTech, Diagnostics and Digital Health space.

    Covering all Healthcare & Life Sciences sectors

    Healthcare Services
    +

    Healthcare Services

    • Provider (Primary-, critical-, outpatient-care service providers)
    • Home-care providers
    • Medical Laboratories
    • Insurances
    • Pharmacies
    Pharma/Biotech
    +

    Pharma/Biotech

    • Discovery & pre-clinical development
    • Clinical Trials
    • Manufacturing
    • Distribution
    • Sales & Marketing
    Medtech
    +

    Medtech

    • Medical Devices
    • Medical Consumables
    • Wholesale and trade
    • R&D
    • Contract Manufacturing
    • Regulatory Consulting
    Diagnostics
    +

    Diagnostics

    • In Vitro Diagnostics
    • Imaging Diagnostics
    • Point-of-Care Testing
    • Molecular Diagnostics
    • Digital Pathology & AI Diagnostics
    Software
    +

    Software

    • Electronic Health Records
    • Telemedicine and Telehealth Platforms
    • Healthcare Data Analytics
    • Clinical Decision Support Systems
    • Patient Engagement and Portal Solutions
    • Cybersecurity and Data Privacy
    • Healthcare Workflow Automation

    We, repeatedly, have been working with Vinc Advisory as they are a real expert consulting organization for the pharma and pharma services industry – and with them combining extensive corporate finance know-how with a strong track record and access to all necessary functional experts in assessing business opportunities, they are able to provide preeminent advice for making our investment decisions. Beyond transaction tactics and deal structuring, they have been supporting us in quickly gaining a comprehensive understanding of business models, quality of technological and service offerings, uncovering hidden value potentials as well as potential risk factors from a financial, operational and strategic point of view. They have been a great sparring partner in various M&A projects and it has been always a pleasure working with the Vinc team.

    Frank Rotmann
    Co-Founder - pharma&, CH

    We experienced Vinc as extremely knowledgeable and professional. When it comes to Life Sciences, their deep sector expertise and global network is a real asset and unusually broad for an M&A firm of their size; we were positively surprised. They also did a great job for the sellers where they had to manage conflicting interests of various parties involved within a very short time period. We look forward to working with them in the future.

    Alexander Zamora
    Partner - Capiton, DE

    We were very pleased with the support from Vinc during the entire process of the sale of our business. We really welcome the opportunity of the GBA Laboratory Group moving the company forward to the next stages of its growth. Vinc has done a great job. Many thanks for getting what we believe was the best outcome of this transaction.

    Dr. Christine Batzl-Hartmann
    CEO and founder - Pharmacelsus, DE

    I would like to truly express my appreciation for VINC Advisory. They provided invaluable support in helping to position the company for future growth and opportunities, increasing value for its shareholders.
    Throughout their outstanding experience in the life science and health care sectors they provided keen counsel and identification in the market of the most suitable technology and industrial partner that shall help the company to achieve its ambitious goals and further increase its value.

    Head of Engineering
    Multinational Pharmaceutical/Biotech Company, EU

    The Vinc Team has been one of the very few amongst the advisory firms to demonstrate an intimate understanding of our CDMO industry, thus clearly standing out. Their expertise is clear and precious and their approach is professional and pragmatic, clearly going the extra mile to bring value.

    Head of Corporate Development
    Top 10 Drug Product CDMO, EU

    Bio-Pharma Future Optimism Score 2025

    Get unique insights into Europe’s SME bio-pharma key strategic topics. CEOs and top management of small- and medium-sized companies from all over Europe share their latest views and give an outlook into the future.

    Get your free copy

    Thank you! Here is your download.
    Download report (PDF)
    Oops! Something went wrong while submitting the form.

    Get in touch

    We look forward to discussing your specific needs and to developing a compelling project for you internationalisation, value creation and growth.

    Get in touch

    Dedicated Advisory Team focussed exclusively on the Healthcare and Life Sciences industries

    Team

    Our Team has extensive deal-making experience, deep sector knowledge and strong personal relationships with the key decision makers in the Life Sciences industry. Combined with our passion, dedication and determination we’re able to provide a particular value-add for your project and/or transaction.

    +
    Thomas Kern
    Founder and Partner

    Thomas Kern

    Founder and Partner

    Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his clients. Building bridges between company owners and investors, constructing compelling equity stories, deal moderation and negotiation are his speciality.

    Previously: Citi, Deutsche Bank, MP Corporate Finance

    +
    Manfred Stadler
    Partner

    Manfred Stadler

    Partner

    Manfred has M&A, Management, Finance and Controlling expertise; Life Sciences and API Experience in Corporate Strategy and M&A, Head of BD and CFO roles. He has lived and worked in various countries (US, UK, CH, D, A) and industries (Pharma, Chemical, Communications) and gathered both, management and consulting  experience and skills. His deep understanding of the industry, of valuing and integrating businesses, makes him a valuable partner in transaction and transformation processes.

    Previously:  Kybora, Cambrex, Lonza, DDB, Mobil Oil

    +
    Hervé Mouneyrac
    Partner

    Hervé Mouneyrac

    Partner

    Hervé has extensive CDMO expertise, with particular focus on strategy and value creation, corporate acquisition and integration processes, as well as business development and cost reduction initiatives. He has had a transforming impact in CDMO on an international scale. With his creative and pragmatic problem solving skills he generates competitive advantage for his clients, defining a vision and aligning the organization to deliver it, thanks to his deep understanding of the industry.

    Previously:  Famar, Masai, Renault

    +
    Robin Knöbl
    Manager

    Robin Knöbl

    Manager
    +
    Felix Stahl
    Associate

    Felix Stahl

    Associate
    +
    Jacob Jasper
    Associate

    Jacob Jasper

    Associate
    +
    Chiara Dirkes
    Partnership Associate

    Chiara Dirkes

    Partnership Associate
    +
    Alen Taric
    Analyst

    Alen Taric

    Analyst
    +
    Lukas Wallner
    Analyst

    Lukas Wallner

    Analyst

    Our specialization: creating actionability through the build-up of very structured or targeted deal pipelines, a meticulously orchestrated omni-channel approach execution strategy combined with creative and solution-oriented strategic as well as tactical advice.

    Thomas Kern
    Managing Director

    Full range of strategic advisory and execution support for transformational projects

    Our Value-Add

    • Exclusive life sciences industry focus for an unobstructed view
    • Tailor-made and solution-oriented project execution
    • Patience and adjusted to your pace in finding the right partner
    • Focused on executing strategies rather than “only” a transaction
    • Shield for emotions
    • Clear and dedicated industry focus
    • Mediator between investors and entrepreneurs
    • Acquisition strategy and structured Buy-Side advice instead of „Lucky Shots“
    • Exit strategy as well as pre- and post-transaction advice
    • Highest quality IB services for mid-market transactions
    • Deep industry entrenchment to find the right sparring partner/target
    • Strategic advisory support
    • Hands-on and solution oriented approach
    • Management interruption at min. level and negotiation power at max. level
    • Assertive negotiation on your behalf to avoid jeopardizing future relationships
    • Focused on overall corporate strategy
    • Pragmatism, speed, olution-orientation and discretion
    • Comprehensive and committed Buy-Side execution
    • Access to solution providers for divestments
    • Special committee advisory - cut to the chase
    • Access and benefit from a deep knowledge pool and insights into the healthcare and life sciences industry
    • Direct c-level exposure to industry leading companies
    • Close client relationships, developing a profound understanding of their needs and strategic goals
    • Directly shaping the future of Healthcare and Life Sciences
    • Engage in a collaborative setting, learn from seasoned professionals, and benefit from mentorship and direct feedback

    We Are a Society. Bringing Together Smart, Entrepreneurial, Experienced, and Passionate People

    Culture

    Inclusive

    We offer opportunities within
    our society to everyone.

    People-oriented

    We believe in the power of
    network and people.

    Open-minded

    Think outside the box.

    Beyond Zeitgeist

    We live in the future guided
    by our purpose.

    Passion

    We believe only passion
    makes one exceptional and
    ensures businesses
    flourishes. And, being
    passionate ourselves, we
    push the limits and improve
    constantly.

    Get in touch with us

    Contact

    We like to listen and to understand. And we’re happy to discuss your specific case and to share our ideas – hands-on, pragmatic, concise. Here’s how you can reach us:

    VINC Healthcare GmbH
    Life Sciences and Healthcare Strategic Transaction Advisory
    Rathausstrasse 11
    1010 Vienna, Austria

    contact@vinc-healthcare.com
    +43 1 361 66 63-0

    ISP Healthcare GmbH
    Life Sciences and Healthcare Investment Strategy Partners
    Herrnstraße 44
    80539 Munich, Germany

    contact@isp-healthcare.com
    +49 151 57168986

    VIENNA – MUNICH

    Legal info
    Privacy policy